Emerging prognostic factors in Nasopharyngeal carcinoma.

Identification and validation of prognostic factors in NPC has been mainly performed in areas where the disease is endemic. It is matter of debate if the same variables will retain their impact when applied to non-endemic areas, with prevalence of other histological subtypes and with a different genetic background.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.15383/JNPC.8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of a prognostic score model for nasopharyngeal carcinoma

  2015cited by this paper
• Prognostic model for distant metastasis in locally advanced nasopharyngeal carcinoma after concurrent chemoradiotherapy

  2015cited by this paper
• Involvement of both Cervical Lymph Nodes and Retropharyngeal Lymph Nodes has prognostic value for N1 patients with Nasopharyngeal Carcinoma

  2014cited by this paper
• Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma

  2014cited by this paper
• Epstein‐Barr virus‐encoded RNAs as a survival predictor in nasopharyngeal carcinoma

  2014cited by this paper
• A four‐miRNA signature identified from genome‐wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma

  2014cited by this paper
• Prognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma

  2014cited by this paper
• Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

  2014cited by this paper
• Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

  2014cited by this paper
• Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma

  2014cited by this paper
• Clinical significance of TrkB expression in nasopharyngeal carcinoma.

  2014cited by this paper
• Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma

  2014cited by this paper
• Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma

  2014cited by this paper
• Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma

  2014cited by this paper
• Primary tumor volume should be included in the TNM staging system of nasopharyngeal carcinoma.

  2014cited by this paper
• Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients

  2014cited by this paper
• Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis

  2013cited by this paper
• Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

  2013cited by this paper
• Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma

  2013cited by this paper
• Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population

  2013cited by this paper
• Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma

  2013cited by this paper
• Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study

  2013cited by this paper
• Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma

  2013cited by this paper
• Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

  2013cited by this paper
• TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma

  2013cited by this paper
• Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: A meta‐analysis

  2013cited by this paper
• Prognostic Value of HIFs Expression in Head and Neck Cancer: A Systematic Review

  2013cited by this paper
• High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in nasopharyngeal carcinoma.

  2013cited by this paper
• Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma

  2013cited by this paper
• Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium

  2013cited by this paper
• Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma

  2013cited by this paper
• Nuclear p27 Expression Confers a Favorable Outcome for Nasopharyngeal Carcinoma Patients

  2013cited by this paper
• Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy

  2013cited by this paper
• Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma

  2013cited by this paper
• The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy

  2013cited by this paper
• Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma.

  2013cited by this paper
• Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.

  2013cited by this paper
• Clinical Significance of Joint Detection of CD44v6 and CD62P in Nasopharyngeal Carcinoma

  2013cited by this paper
• Value of Magnetic Resonance Diffusion-Weighted Imaging for the Prediction of Radiosensitivity in Nasopharyngeal Carcinoma

  2013cited by this paper
• Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy

  2013cited by this paper
• Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials.

  2013cited by this paper
• Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.

  2013cited by this paper
• Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.

  2013cited by this paper
• Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein–Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma

  2013cited by this paper
• Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study

  2012cited by this paper
• A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.

  2012cited by this paper
• To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area.

  2012cited by this paper
• The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

  2012cited by this paper
• Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma

  2012cited by this paper
• Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?

  2012cited by this paper
• Upregulation of Gp96 Correlates with the Radiosensitivity and Five-Year Survival Rate of Nasopharyngeal Carcinoma

  2012cited by this paper
• Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.

  2011cited by this paper
• Plasma Epstein‐Barr virus DNA screening followed by 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma

  2011cited by this paper
• Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma

  2011cited by this paper
• Prognostic Impact of Standardized Uptake Value of F-18 FDG PET/CT in Nasopharyngeal Carcinoma

  2011cited by this paper
• Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

  2011cited by this paper
• Prognostic significance of expression of vegf and cox‐2 in nasopharyngeal carcinoma and its association with expression of C‐erbB2 and EGFR

  2011cited by this paper
• Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification

  2011cited by this paper
• Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival.

  2011cited by this paper
• Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.

  2010cited by this paper
• Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma

  2010cited by this paper
• Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma.

  2010cited by this paper
• Human papillomavirus and WHO type I nasopharyngeal carcinoma

  2010cited by this paper
• Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma

  2010cited by this paper
• Elevated Beclin 1 expression is correlated with HIF-1α in predicting poor prognosis of nasopharyngeal carcinoma

  2010cited by this paper
• Prognostic impact of magnetic resonance imaging‐detected cranial nerve involvement in nasopharyngeal carcinoma

  2009cited by this paper
• HPV‐positive/p16‐positive/EBV‐negative nasopharyngeal carcinoma in white North Americans

  2009cited by this paper
• Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

  2009cited by this paper
• Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

  2008cited by this paper
• Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.

  2008cited by this paper
• Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

  2008cited by this paper
• Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy

  2007cited by this paper
• Application of 18F-FDG PET/CT in Nasopharyngeal Carcinoma

  2007cited by this paper
• Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

  2007cited by this paper
• Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.

  2007cited by this paper
• Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area

  2006cited by this paper
• Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.

  2006cited by this paper
• Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging

  2006cited by this paper
• Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

  2006cited by this paper
• Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

  2006cited by this paper
• Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).

  2006cited by this paper
• Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.

  2006cited by this paper
• Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.

  2006cited by this paper
• A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma

  2005cited by this paper
• Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.

  2005cited by this paper
• Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.

  2005cited by this paper
• Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.

  2005cited by this paper
• Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

  2005cited by this paper
• Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma

  2005cited by this paper
• The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature.

  2004cited by this paper
• Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.

  2004cited by this paper
• Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.

  2004cited by this paper
• Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy

  2004cited by this paper
• [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].

  2004cited by this paper
• Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.

  2003cited by this paper
• Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma.

  2003cited by this paper
• Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging.

  2003cited by this paper
• Design of a prognostic index score for metastatic nasopharyngeal carcinoma.

  2003cited by this paper
• Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type

  2003cited by this paper
• Molecular pathology parameters in human nasopharyngeal carcinoma

  2002cited by this paper

• Cyclooxygenase-2 Expression and Its Correlation with Primary Tumor Size and Lymph Node Involvement in Nasopharyngeal Carcinoma

  2018cites this paper
• The value of 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography (18F- FDG PET/CT) in the staging and impact on the management of patients with nasopharyngeal carcinoma

  2017cites this paper